positive patients was significantly higher than in DYT1 -negative patients. The mean age at onset was 8.6 8 1.6 years (7-12 years) in DYT1 -positive patients, while mean age at onset in patients with no GAG deletion mutation was higher (15.7 8 11.5 years). Conclusions: The DYT1 904-906 del GAG mutation is responsible for some of Iranian dystonia patients, and screening for the DYT1 deletion is significant in cases with the generalized type of primary dystonia. Also, patients with leg or arm onset at a younger age are more likely to be DYT1 -positive among primary torsion dystonia cases.
Introduction
Dystonia is a group of movement disorders that are characterized by sustained muscle contractions causing twisting, repetitive movements or abnormal postures, affecting one or more sites of the body [1] . Dystonia is classified as either primary or secondary. Among primary dystonias, DYT1 dystonia manifests autosomal dominant inheritance with low penetrance (30-40%) and is 463 usually the only symptom of the disease [2] . It is caused by a mutation in the DYT1 (also termed TOR1A ) gene (9q34), which mainly leads to a 3-bp deletion (GAG) in exon 5 and subsequently results in loss of a glutamic acid residue in the protein torsin A [3, 4] . Primary dystonia is also termed primary torsion dystonia (PTD), and its onset typically is either during childhood (early onset around the age of 9 years) or in rare cases during adulthood (late onset at 45 years). Usually, disease onset is before the age of 26 years [1, 2] . In the secondary forms, dystonia is usually caused by an underlying disease which can be either genetic or environmental [5] [6] [7] .
Dystonia can also be classified into different subtypes according to the part of the body affected: focal (affecting one body part, such as neck or leg), segmental (affecting two adjacent areas like head and neck), multifocal (two nonadjacent areas are involved, such as two arms), hemidystonia (when it is confined to one side of the body) and generalized [8, 9] . Most of PTDs begin with involvement of a limb in childhood with gradual progression to the generalized form [6] .
The purpose of this study was to determine the rate of DYT1 mutation in a consecutive series of Iranian patients with PTD, and to investigate the association of this mutation with phenotypic characteristics of dystonia, which are highly variable.
Subjects and Methods
Seventy-two unselected non-Jewish dystonia patients (42 males, 30 females) were examined by three neurologist physicians over 4 years; 9 were described as secondary dystonia patients due to birth incidents, limb injuries, an underlying disease or infection, or side effects of drugs [9, 10] , and these patients were excluded from this study. The Ethics Committee of the Pasteur Institute of Iran approved this study. Following written informed consent for genetic studies from the remaining 63 patients, 10 ml peripheral blood was taken from each individual, collected in EDTA tubes and kept at -20 ° C. Whole-blood DNA extraction was carried out by standard method of salting out. Amplification of exon 5 of the TOR1A gene was performed by PCR using forward and reverse primers ( DYT1 F 5 -CCTGGAATACAAACACCTA-3 , DYT1 R 5 -GGCTGCCAATCATGACTGTC-3 ). The PCR conditions for amplification of exon 5 of the TOR1A gene are as follows: one cycle at 94 ° C for 5 min, 94 ° C for 1 min, 60 ° C for 1 min, 72 ° C for 1 min in 32 cycles, and finally one cycle at 72 ° C for 5 min. Then sequencing was performed using ABI XL Sequencer (Applied Biosystems, Foster City, Calif., USA) as described elsewhere [11] .
For statistical analysis, quantitative variables were expressed as means 8 SD while qualitative variables were expressed as percentages.
Results
Ten cases out of 63 PTD patients (15.9%) were positive for GAG deletion in DYT1 (TOR1A). The electrophoresis of a DYT1 -positive patient in comparison with the normal sequence is shown in figure 1 . Clinical data were available for 48 (76.2%) of the 63 primary dystonia patients. In the DYT1-positive cohort, clinical data were available for 8 (80%) of the patients, and in the DYT1-negative cohort, clinical data were available for 40 (75.5%) ( table 1 ).
The mean age of the DYT1-positive cohort, negative cohort and all available (n = 48) patients was 15.1 8 8.4 (range 8-34), 22.3 8 10.8 (range 6-54), and 21.1 8 10.8 years (range 6-54), respectively. Almost all of these 48 patients were unrelated cases, except 2 ( table 1 ), who were second cousins. Among the positive patients, 3 had positive family history and all but 1 patient had the generalized type of dystonia; mean age at onset was 8.6 8 1.6 years ( table 1 ), while mean age at onset in DYT1 mutationnegative patients was higher (15.7 8 11.5 years).
In all PTD patients, limbs were the most severely involved sites at the time of onset: hand and arm 45.83%; foot and leg 25%, and in most cases it had developed to the generalized form (50%). The difference between sites of onset in the majority of DYT1 -positive cases in com- A AE = Age at examination; AAO = age at onset; R = right; L = left; NA = not available. parison with negative patients was an outstanding result, which showed higher arm onset in DYT1 -negative (50%) in contrast to higher leg onset in positive (62.5%) patients. Also, the progression to the generalized form of dystonia in DYT1 -positive patients was significantly higher (p = 0.047) than in DYT1-negative patients (87.5% in DYT1-positives and 42.5% in DYT1-negatives). These data are summarized in table 2 , and there are data about the latest type of dystonia -at the time of writing the article -in all available patients with regard to their sites of onset in table 3 . In addition, in these 48 available patients, females had earlier onset of dystonia (12 8 5.5) compared with males (15 8 13), and except for those 3 positive patients none of them had a positive family history ( table 1 ) . We also had a rare finding: a late-onset negative patient with leg onset at the age of 48 whose disease had progressed to the generalized form within 6 years of onset (involving limbs, trunk, neck and face).
Discussion
Dystonia is a severe disease in most cases. Although primary dystonia is infrequent in the general population, it affects all aspects of a patient's life. Considering the fact that Jewish communities are closed with regard to marriage with non-Jewish populations, the likelihood of admixture with the Iranian population is very remote. To the best of our knowledge there has been no previous report about its clinical features, mutation screening, or genotype-phenotype correlation amongst people of Iran or neighboring countries prior to this report. We reported 63 Iranian non-Jewish patients with primary dystonia with a high frequency of DYT1 mutation, comparing with other populations [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] .
In this study, mean age at onset of DYT1 mutationpositive and DYT1 mutation-negative patients was 8.6 8 1.6 and 15.7 8 11.5, respectively. In comparison with some previous data, we had earlier age at onset [12] [13] [14] 26] . However, our patients showed a later age at onset than Italians [15] . The data about age at onset in females and males (females 12 8 5.5, males 15 8 13) is also unlike most of previously published data, which showed earlier age at onset in males [16, 17, 27] .
With regard to generalization rates (87.5% in positive and 50% in overall PTD patients), while most of our patients had generalized form, most patients in other studies have been reported with focal dystonia [17, 26, 28] . It might be because of our patients' earlier age at onset, since according to some data, later onset age may protect the patient from disease progression [18] . Alternatively, some patients with focal or even segmental dystonias may not have sought proper treatment and remained undiagnosed.
The patient with onset at 48 years was remarkable due to having generalized dystonia, which more often occurs in early-onset patients [12, 29] , although there were also 3 patients in a German study who presented with generalized dystonia with age at onset over 40 years [28] .
Overall, as a result of this study and according to the guidelines of the European Federation of Neurological Societies [18] , molecular testing for GAG deletion in the DYT1 gene is recommended in cases with early-onset primary dystonia regardless of family history, especially in those who suffer from the generalized type. The DYT1 904-906 del GAG mutation was responsible for the dystonia of some Iranian patients, and screening for the DYT1 deletion is important in cases with the generalized type of primary dystonia. Also, patients with leg or arm onset at a younger age were more likely to be DYT1 -positive among primary torsion dystonia cases.
